Format

Send to

Choose Destination
Diagn Microbiol Infect Dis. 2014 Dec;80(4):327-9. doi: 10.1016/j.diagmicrobio.2014.09.002. Epub 2014 Sep 6.

Serum inhibitory and bactericidal activity of telavancin in non-infected subjects with severe renal impairment or end-stage renal disease.

Author information

1
Theravance Biopharma US, Inc., 901 Gateway Boulevard, South San Francisco, CA 94080, USA. Electronic address: SBarriere@theravance.com.
2
JMI Laboratories, 345 Beaver Kreek Center, Suite A, North Liberty, IA 52317, USA.

Abstract

Telavancin biological activity, determined by serum titers against a reference strain of Staphylococcus aureus, was maintained in the serum of subjects with severe renal impairment or end-stage renal disease suggesting that there is no apparent effect of renal function on in vitro activity of telavancin.

KEYWORDS:

Renal impairment; Staphylococcus aureus; Telavancin

[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center